Copeptin with high-sensitivity troponin at presentation is not inferior to serial troponin measurements for ruling out acute myocardial infarction
Kyung Su Kim, Gil Joon Suh, Sang Hoon Song, Yoon Sun Jung, Taegyun Kim, So Mi Shin, Min Woo Kang, Min Sung Lee
Clin Exp Emerg Med. 2020;7(1):35-42.   Published online 2020 Mar 31     DOI:
Citations to this article as recorded by Crossref logo
Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases
Danni Mu, Jin Cheng, Ling Qiu, Xinqi Cheng
Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
Copeptin plus troponin in the rapid rule out of acute myocardial infarction and prognostic value on post-myocardial infarction outcomes: a systematic review and diagnostic accuracy study
Sheref A. Elseidy, Ahmed K. Awad, Debvarsha Mandal, Mounika Vorla, Ahmed Elkheshen, Tamam Mohamad
Heart and Vessels.2022;[Epub]     CrossRef
Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients
Lukasz Szarpak, Marcin Lapinski, Aleksandra Gasecka, Michal Pruc, Wiktoria L. Drela, Mariusz Koda, Andrea Denegri, Frank W. Peacock, MiƂosz J. Jaguszewski, Krzysztof J. Filipiak
Journal of Cardiovascular Development and Disease.2021; 9(1): 6.     CrossRef
Serum exosomal miR-122-5p is a new biomarker for both acute coronary syndrome and underlying coronary artery stenosis
Hao Ling, Ziyuan Guo, Shuangshuang Du, Yinghong Liao, Yunyan Li, Chao Ding, Chunli Song
Biomarkers.2020; 25(7): 539.     CrossRef